<?xml version="1.0" encoding="UTF-8"?>
<ref id="B130-diagnostics-10-00409">
 <label>130.</label>
 <element-citation publication-type="web">
  <article-title>Pfizer and BioNTech Dose First Participants in the U.S. as Part of Global COVID-19 mRNA Vaccine Development Program|Pfizer</article-title>
  <comment>Available online: 
   <ext-link ext-link-type="uri" xlink:href="https://www.pfizer.com/news/press-release/press-release-detail/pfizer_and_biontech_dose_first_participants_in_the_u_s_as_part_of_global_covid_19_mrna_vaccine_development_program" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.pfizer.com/news/press-release/press-release-detail/pfizer_and_biontech_dose_first_participants_in_the_u_s_as_part_of_global_covid_19_mrna_vaccine_development_program</ext-link>
  </comment>
  <date-in-citation content-type="access-date" iso-8601-date="2020-05-12">(accessed on 12 May 2020)</date-in-citation>
 </element-citation>
</ref>
